Zolnorem 12,5 mg Tablet
PDF Leaflet Revision Date: 14 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Short term treatment of severe insomnia in adults under 65.
Dosage (summary)
12.5 mg orally before bedtime; max 12.5 mg, not to exceed 4 weeks.
Onset of Action / Duration
Onset: Rapid, Duration: 6-8 hours
Special Populations
- Hepatic impairment
- Elderly (> 65 years)
- Paediatric patients (< 18 years)
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CNS depressants
- Alcohol
- Opioids
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity to zolpidem
- Severe hepatic impairment
- Sleep apnoea syndrome
- Myasthenia gravis
- Pregnancy and lactation
Common side effects
- Somnolence
- Dizziness
- Headache
- Anxiety
Counselling Points
- Take immediately before bedtime.
- Avoid alcohol and CNS depressants.
- Do not drive or operate machinery after use.
- Report any unusual behaviors or side effects.
Serious warnings
- Risk of dependence
- Amnesia
- Psychomotor impairment
- Rebound insomnia
Important Disclaimer
The Zolnorem 12,5 mg Tablet professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
